(Bloomberg) — Alibaba Group Holding Ltd.’s U.S.-listed shares have never been this cheap and yet investors keep bailing.
Most Read from Bloomberg
Reliving the New York Subway Map Debate
China Cash Flowed Through Congo Bank to Former President’s Cronies
‘Pension Poachers’ Are Targeting America’s Elderly Veterans
‘Ghost Signs’ Haunt London’s Reviving Neighborhoods
On a reported earnings basis, Alibaba’s American depositary receipts trade at a multiple of 18.7. That’s the lowest since its 2014 debut, and the widest discount to the Nasdaq 100 Index’s average multiple on record. The ADRs slumped 4% on Wednesday to a level not seen since May 2017. Its Hong Kong shares slid 3.7% at 10:49 a.m. local time.
A rout that’s wiped $526 billion in value in 13 months is deepening amid concern over the company’s outlook. Some of Alibaba’s biggest growth drivers — fintech, data, online advertising and content — are under scrutiny from regulators in Beijing. The company missed estimates for quarterly sales at its latest earnings update last month and predicted slowing revenue growth for 2022.
There’s also uncertainty over the future of tech companies such as Alibaba that used variable interest entities to get around foreign ownership rules and list overseas. China is planning to ban companies from going public on foreign stock markets through VIEs, people familiar with the matter said.
The China Securities Regulatory Commission said on its website Wednesday that a media report about banning the overseas listings of companies using the VIE structure is not true, without giving further details.
Those betting the shares are too cheap and ripe for a turnaround keep getting steamrolled. Derivatives traders who had bought bullish Alibaba options capitulated on their bets this week, selling thousands of December calls at steep losses. A bearish put expiring in just over two weeks is by far the most owned contract. Its $20 strike price implies an 84% drop from Wednesday’s close.
Wall Street analysts are scrambling to keep pace with the declines in the ADRs. While they are overwhelmingly bullish — with 56 buy recommendations to one sell — the average price target for the firm has fallen for 18 straight weeks.
Most Read from Bloomberg Businessweek
Paige Bueckers, a College Athlete Who’s Cashing In
Karen Lynch, the Shot Caller at CVS
Charlie Penner, the Investor Reshaping Exxon From the Inside
David Baszucki, Roblox’s ‘Builderman’
©2021 Bloomberg L.P.
